Aditya S. Ivacaftor in cystic fibrosis: the first disease modifying agent. Int J Basic Clin Pharmacol [Internet]. 2017 Feb. 4 [cited 2025 Oct. 24];1(3):225-9. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/1433